Preclinical study of goat milk kefir as an antihyperglycemic food

Authors

  • Siti Susanti Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia
  • Nurwantoro Nurwantoro Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia
  • Jessen Juan Elto Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia
  • Trilaksana Nugroho Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • Ade Erma Suryani Research Center for Food Technology and Processing-National Research and Innovation Agenc
  • Heni Rizqiati Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia

DOI:

https://doi.org/10.31989/ffhd.v12i12.987

Abstract

Background: Goat milk kefir is a functional food with numerous health benefits, including blood sugar control, cholesterol reduction, and improved digestive health. This study aims to determine the effect of kefir consumption on blood glucose levels in hyperglycaemic mice (Mus musculus) without affecting another blood chemistry.  This study compared goat milk kefir products to other processed milk products considered to be capable of controlling and reducing blood sugar levels. 

Objective:This study aimed to compare goat milk kefir products to other processed food products considered to be capable of controlling and reducing blood sugar levels.

Methods: Twenty-one mice, as experimental animals, were induced for 21 days with the high-fat and high fructose diet to increase blood sugar levels. After induction, mice were divided into 3 groups according to treatment, namely oral administration of additional distilled water (placebo), diabetasol® (positive control), and goat's milk kefir with each group consisting of 9 individuals. 

Results: Treatment showed significant effect on the blood glucose and β-ketone level. Diabetasol®  and Goat kefir supplemented mice had a lower blood glucose level than control (p < 0.05) and goat kefir supplemented mice had lower blood β-ketone level than control and Diabetasol® (p< 0.05). Meanwhile, hematocrit and hemoglobin levels did not show significant differences between treatments.

Conclusion: The results suggested that goat milk kefir has preclinical potential as an antihyperglycemic functional food without affecting other blood chemistry profiles.

Keywords: Antihyperglycemic, blood sugar, goat kefir

Downloads

Published

2022-12-08

Issue

Vol. 12 No. 12 (2022): December 2022

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.